Marshall Wace Asia’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,659,686
Closed -$14.7M 116
2020
Q1
$14.7M Sell
1,659,686
-885,530
-35% -$12.8M 0.4% 38
2019
Q4
$46M Buy
2,545,216
+671,281
+36% +$11.1M 1.14% 36
2019
Q3
$28M Buy
+1,873,935
New +$30.5M 0.67% 56
2019
Q2
Sell
-1,632,488
Closed -$60.7M 107
2019
Q1
$60.7M Buy
+1,632,488
New +$59.4M 1.83% 24

Other funds holding CC

Marshall Wace Asia's CC Position: Q2 2020 in Review

Marshall Wace Asia sold out of Chemours (CC) in Q2 2020, closing a stake of 1,659,686 shares — an estimated $14.7M sold.

Marshall Wace Asia first reported a position in CC in Q1 2019 and held it in 4 quarters. The position peaked at $60.7M in Q1 2019. 396 funds tracked by Wall St. Rank hold CC as of Q2 2020.

  • Marshall Wace Asia reported no remaining Chemours position as of Q2 2020 after selling out during the quarter.
  • Marshall Wace Asia sold 1,659,686 Chemours shares in Q2 2020, an estimated $14.7M.
  • Marshall Wace Asia first reported a position in Chemours in Q1 2019 and held it in 4 quarters.
  • Marshall Wace Asia's Chemours position peaked at $60.7M in Q1 2019.
  • 396 funds tracked by Wall St. Rank held Chemours as of Q2 2020.

Based on Marshall Wace Asia's 13F filing for Q2 2020, filed 13 Aug 2020.